$CANB Uptick Newswire Hosts Canbiola Inc. on the S
Post# of 266
(Total Views: 247)
Posted On: 01/31/2019 8:09:01 AM
$CANB Uptick Newswire Hosts Canbiola Inc. on the Stock Day Podcast to Discuss its Recent Acquisition of HudiLab Inc. and Share Their Expectations for the FuturePress Release | 01/31/2019
PHOENIX, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Canbiola Inc. (CANB), a US company embarking in the sale of a variety of Cannabidiol (CBD) based products, to discuss their recent acquisition of HudiLab Inc. and the advantages of their wholly owned subsidiary, DuraMed Inc. CFO, Stan Teeple, joined Stock Day host Everett Jolly.
Jolly began the interview by asking Teeple to offer insight into the Company and what they do. Teeple shared that they are a CBD company that focuses on the hemp side of the plant, which allows them to specialize on its medical and wellness benefits. “Everything that we’re about is CBD based. Every product we have, every subsidiary we have, we’re driven in the CBD space.”
Teeple then discussed the Company’s recent acquisition of HudiLab Inc., which developed a CBD infused pad that allows users to absorb CBD through the skin to help with joint pain. Teeple shared his excitement for this acquisition and his belief that the revenue will be reflected on the first or second quarter of 2019.
Jolly then asked Teeple to expand on the Company’s wholly own subsidiary, DuraMed Inc. Teeple stated, “What we’ve created with our DuraMed division is a rental program where we provide doctors who treat injured patients with the SAM unit. The doctors then turn around and rent these units to their patients, and the patients take it home with them.”
Teeple explained that this is an extremely effective way for patients to heal their injury due to its deep penetration through the skin. He then shared that beta testing has confirmed its effectiveness, and that the potential revenues from these rentals will be exponential.
With HudiLab Inc., the Company is able to further improve the SAM unit’s effectiveness by incorporating the CBD infused pads with its use.
Teeple then shared his excitement for the future and stated that he is open to any acquisition that can bring value and opportunity to the Company, especially in terms of technology. To close the interview Teeple encouraged listeners to browse the Company’s website and keep their goals for the future in mind.
To hear more about Canbiola Inc., listen to the full podcast here: https://upticknewswire.com/featured-interview...qb-canb-2/
Investors Hangout is a proud sponsor of “Stock Day,” and Uptick Newswire encourages listeners to visit the company’s message board at https://investorshangout.com/
About Canbiola, Inc.
Canbiola, Inc. is a public company trading under symbol CANB.
Canbiola, Inc. is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure CBD products are legal in all 50 states. The company has already launched several products found at www.canbiola.com.
Forward-looking statements and risks and uncertainties discussed in this letter contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price.
CONTACT INFORMATION:
Canbiola Investor Relations
PHOENIX, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Canbiola Inc. (CANB), a US company embarking in the sale of a variety of Cannabidiol (CBD) based products, to discuss their recent acquisition of HudiLab Inc. and the advantages of their wholly owned subsidiary, DuraMed Inc. CFO, Stan Teeple, joined Stock Day host Everett Jolly.
Jolly began the interview by asking Teeple to offer insight into the Company and what they do. Teeple shared that they are a CBD company that focuses on the hemp side of the plant, which allows them to specialize on its medical and wellness benefits. “Everything that we’re about is CBD based. Every product we have, every subsidiary we have, we’re driven in the CBD space.”
Teeple then discussed the Company’s recent acquisition of HudiLab Inc., which developed a CBD infused pad that allows users to absorb CBD through the skin to help with joint pain. Teeple shared his excitement for this acquisition and his belief that the revenue will be reflected on the first or second quarter of 2019.
Jolly then asked Teeple to expand on the Company’s wholly own subsidiary, DuraMed Inc. Teeple stated, “What we’ve created with our DuraMed division is a rental program where we provide doctors who treat injured patients with the SAM unit. The doctors then turn around and rent these units to their patients, and the patients take it home with them.”
Teeple explained that this is an extremely effective way for patients to heal their injury due to its deep penetration through the skin. He then shared that beta testing has confirmed its effectiveness, and that the potential revenues from these rentals will be exponential.
With HudiLab Inc., the Company is able to further improve the SAM unit’s effectiveness by incorporating the CBD infused pads with its use.
Teeple then shared his excitement for the future and stated that he is open to any acquisition that can bring value and opportunity to the Company, especially in terms of technology. To close the interview Teeple encouraged listeners to browse the Company’s website and keep their goals for the future in mind.
To hear more about Canbiola Inc., listen to the full podcast here: https://upticknewswire.com/featured-interview...qb-canb-2/
Investors Hangout is a proud sponsor of “Stock Day,” and Uptick Newswire encourages listeners to visit the company’s message board at https://investorshangout.com/
About Canbiola, Inc.
Canbiola, Inc. is a public company trading under symbol CANB.
Canbiola, Inc. is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure CBD products are legal in all 50 states. The company has already launched several products found at www.canbiola.com.
Forward-looking statements and risks and uncertainties discussed in this letter contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price.
CONTACT INFORMATION:
Canbiola Investor Relations
(0)
(0)